DVAX primary drug pipeline asset is HEPLISAV -B. View DVAX stock price, stock chart, latest news, News See all news Heplisav ; 03 April 2017 What Dynavax Technologies Holders Need to Consider Heading Into the Heplisav -B PDUFA.
This page contains the latest News about the Dynavax stock. What Dynavax Technologies Holders Need to Consider Heading Into the Heplisav -B PDUFA...
News what dynavax technologies holders need consider heading into heplisavb pdufa -- flyingThere is also evidence to suggest the vaccine maintains an improvement in seroprotection over current treatments in the immunosuppressed populations described earlier as having a weak or no response to the currently available vaccines — elderly, renal disease sufferers, diabetes patients and so on. Be Your Own Boss. In short, the market needs an upgraded alternative to what is available.
Dynavax Technologies Corp - DVAX Stock Chart Technical Analysis for 10-03-16